D
Cellebrite DI Ltd. CLBT
$18.25 $0.975.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2024 12/31/2023 09/30/2023 06/30/2023
Revenue -- 20.12% 15.72% 13.47%
Total Other Revenue -- -- -- --
Total Revenue -- 20.12% 15.72% 13.47%
Cost of Revenue -- 4.90% -0.99% 7.71%
Gross Profit -- 23.63% 19.70% 14.80%
SG&A Expenses -- 11.58% 5.20% 1.69%
Depreciation & Amortization -- -- -- --
Other Operating Expenses -- -- -- --
Total Operating Expenses -- 8.26% 3.47% 5.73%
Operating Income -- 3,083.62% 745.51% 310.84%
Income Before Tax -- -162.57% -132.64% -123.46%
Income Tax Expenses -- 12,404.44% 2,905.14% -44.68%
Earnings from Continuing Operations -- -167.13% -135.85% -127.44%
Earnings from Discontinued Operations -- -- -- --
Extraordinary Item & Accounting Change -- -- -- --
Minority Interest in Earnings -- -- -- --
Net Income -- -167.13% -135.85% -127.44%
EBIT -- 3,083.62% 745.51% 310.84%
EBITDA -- 307.53% 824.14% 1,125.93%
EPS Basic -- -169.54% -138.55% -129.66%
Normalized Basic EPS -- -200.28% -124.48% -124.48%
EPS Diluted -- -177.87% -143.08% -134.27%
Normalized Diluted EPS -- -205.65% -127.06% -127.06%
Average Basic Shares Outstanding -- 4.08% 3.46% 8.03%
Average Diluted Shares Outstanding -- -0.12% -1.14% 1.30%
Dividend Per Share -- -- -- --
Payout Ratio -- -- -- --
Weiss Ratings